Zhao, Q., Jiang, Y., Xiang, S., Kaboli, P. J., Shen, J., Zhao, Y., . . . Xiao, Z. (2021). Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons. Front Immunol.
Style de citation ChicagoZhao, Qijie, et al. "Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons." Front Immunol 2021.
Style de citation MLAZhao, Qijie, et al. "Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons." Front Immunol 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.